Quick Answer
SUTRO BIOPHARMA, INC. reported Shares Outstanding of 8.58 million shares for fiscal year 2025.
SUTRO BIOPHARMA, INC. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 8.58M | +3.3% |
| 2024 | 8.31M | -86.4% |
| 2023 | 61.01M | +6.1% |
| 2022 | 57.50M | +24.1% |
| 2021 | 46.33M | +1.3% |
| 2020 | 45.75M | +98.1% |
| 2019 | 23.10M | +1.1% |
| 2018 | 22.85M | +4810.1% |
| 2017 | 465,330 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 85.10M | +3.3% | +0.5% |
| June 30, 2025 | 84.72M | +3.5% | +0.4% |
| March 31, 2025 | 84.35M | +35.1% | +2.2% |
| December 31, 2024 | 82.53M | +35.3% | +0.2% |
| September 30, 2024 | 82.40M | +35.3% | +0.7% |
| June 30, 2024 | 81.86M | +35.4% | +31.1% |
| March 31, 2024 | 62.46M | +3.8% | +2.4% |
| December 31, 2023 | 61.01M | +6.1% | +0.2% |
- SUTRO BIOPHARMA, INC. showed an increase of +3.3% in Shares Outstanding compared to the prior fiscal year.
- Over the 2017–2025 period, SUTRO BIOPHARMA, INC.’s shares outstanding has grown by 1744.8% (from 465.3 thousand shares to 8.58 million shares).
- The most recent figure is from SUTRO BIOPHARMA, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: